Metabolic effect of sacubitril-valsartan combination: beware of hypoglycemia!

被引：0
|
作者：
Guetlin, M. [1 ]
Joubert, M. [1 ,2 ]
机构：
[1] CHU Caen, Serv Endocrinol Diabetol, Caen, France
[2] Univ Caen Normandie UNICAEN, Caen, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2024年 / 28卷 / 02期
关键词：
Sacubitril-valsartan; Heart failure with reduced ejection fraction; Diabetes; Hypoglycemia; NEPRILYSIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Sacubitril-valsartan combination, a treatment for heart failure with reduced ejection fraction, also presents metabolic effects on glucose, particularly in patients with diabetes: several studies have shown a reduction in glycated hemoglobin (HbA1c), a reduction in insulin requirements, along with an increase of hypoglycemic risk. While the mechanisms of these metabolic effects are not fully understood, they may involve neprilysin inhibition and increased glucagon-like peptide-1 (GLP1) levels.
引用
收藏
页码：78 / 80
页数：3
相关论文
共 50 条
  • [31] Effects of Cardiovascular Outcomes of Sacubitril-Valsartan in Patients With AKI
    Choi, Hoon Young
    Oh, Donghwan
    Yang, Eunji
    Jhee, Jong Hyun
    Park, Hyeong Cheon
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 350 - 350
  • [32] Sacubitril-valsartan and BNP: Will they live happily ever after?
    Abellas-Sequeiros, M.
    Vieitez Florez, J. M.
    Lorente, A.
    Alonso, G.
    Del Prado, S.
    Del Rey, J. M.
    Zamorano, J. L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 434 - 434
  • [33] Unexpected Case of Sacubitril-Valsartan Induced Brash Syndrome
    Maurer, J.
    Mirchin, R.
    Rhee, J.
    Al-Ghrairi, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [34] Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
    Del Buono, Marco Giuseppe
    Bonaventura, Aldo
    Vecchie, Alessandra
    Wohlford, George F.
    Dixon, Dave L.
    Van Tassel, Benjamin W.
    Abbate, Antonio
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (02) : 105 - 107
  • [35] Safety and efficacy of sacubitril-valsartan in acute heart failure
    Le Bras, Alexandra
    NATURE REVIEWS CARDIOLOGY, 2019, 16 (01) : 4 - 4
  • [36] Effectiveness of sacubitril-valsartan in cancer patients with heart failure
    Martin-Garcia, Ana
    Lopez-Fernandez, Teresa
    Mitroi, Cristina
    Chaparro-Munoz, Marinela
    Moliner, Pedro
    Martin-Garcia, Agustin C.
    Martinez-Monzonis, Amparo
    Castro, Antonio
    Lopez-Sendon, Jose L.
    Sanchez, Pedro L.
    ESC HEART FAILURE, 2020, 7 (02): : 763 - 767
  • [37] The safety of sacubitril-valsartan for the treatment of chronic heart failure
    Tyler, Jeffrey M.
    Teerlink, John R.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 257 - 263
  • [38] Sacubitril-Valsartan for the Treatment of Heart Failure Effectiveness and Value
    Ollendorf, Daniel A.
    Sandhu, Alexander T.
    Pearson, Steven D.
    JAMA INTERNAL MEDICINE, 2016, 176 (02) : 249 - 250
  • [39] Effects of sacubitril-valsartan in patients undergoing maintenance dialysis
    Ding, Ying
    Wan, Li
    Zhang, Zhou-cang
    Yang, Qing-hua
    Ding, Jia-xiang
    Qu, Zhen
    Yu, Feng
    RENAL FAILURE, 2023, 45 (01)
  • [40] SACUBITRIL-VALSARTAN FOLLOWING HOSPITAL DISCHARGE FOR HEART FAILURE
    Cooper, Lauren Beth
    Kaltenbach, Lisa
    Al-Khalidi, Hussein
    Cole, Robert
    Allen, Larry A.
    Fonarow, Gregg C.
    Butler, Javed
    Albert, Nancy M.
    Lanfear, David E.
    Granger, Bradi
    Kociol, Robb
    Pina, Ileana
    Heidenreich, Paul
    Granger, Christopher B.
    Felker, G. Michael
    Lewis, Eldrin
    McRae, Andrew
    Hernandez, Adrian
    DeVore, Adam
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1063 - 1063
12345